Starpharma Holdings Ltd has released a press release.
Starpharma receives US$3M milestone from AstraZeneca
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- Quarterly Cashflow Report
- Commencement of phase 1 trial for AZD0466 utilising DEP
- Starpharma receives $4.9M R&D tax incentive refund
- DEP cabazitaxel progresses to phase 2 on positive results
- AGM - Chairman address and CEO presentation
Later from Starpharma
- VivaGel BV launched in Asia
- Okamoto licenses VivaGel antiviral condom in Asian countries
- Quarterly Cashflow and Activity Report
- SPL7013 shows significant activity against coronavirus
- DEP irinotecan phase 2 commences after positive phase 1
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma